GoKawiilTech billionaires expand funding of biomedical research ahead of AI IPOs
OpenAI and Anthropic are preparing to go public within the next year or two, with Anthropic's IPO potentially raising as much as $2 trillion and OpenAI targeting $1.4 trillion, though OpenAI has pushed its listing to 2027 over AI safety concerns. Researchers note that such windfalls could add to an already growing trend of tech entrepreneurs funneling personal fortunes into biomedical science, citing examples like Altos Labs, which launched in 2022 with $3 billion from investors including Yuri Milner and Jeff Bezos, and the Chan Zuckerberg Initiative.
GoKawiil's interpretation of the reporting above, not reported fact.
MIT's Andrew Lo suggests the anticipated IPO windfalls could unlock fresh waves of private investment and philanthropy aimed at areas like longevity, cancer biology and reproductive technology, potentially reshaping how biomedical research gets funded outside traditional grant systems. Because this money flows through personal donations and private companies rather than public agencies, it could concentrate influence over research priorities among a small number of wealthy individuals.
- Anthropic and OpenAI are both planning IPOs, with Anthropic's potentially reaching $2 trillion and OpenAI's $1.4 trillion.
- OpenAI has delayed its IPO to 2027 amid AI safety concerns.
- Tech fortunes have already funded major biomedical ventures like Altos Labs ($3 billion) and the Chan Zuckerberg Initiative, a trend experts expect to accelerate.
Source: nature.com — Ledford, 2026-10-21
Published there as: “How tech billionaires are disrupting biomedical science”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.